Action Idorsia - 19T

Idorsia Ltd (19T) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

7,21

( 1,98% )

Prix Achat

7,175

Prix Vente

7,245

Volume échangé

2 709

7,07 Fourchette du Jour 7,355

2,375 Plage de 52 semaines 8,19

Clôture Veille

7,07

Ouverture

7,13

Dernière Transaction

7.245

Dernière heure de transaction

Volume moyen (3 m)

9 476

Volume financier

VWAP

Idorsia appoints Roland Wandeler as Chief Executive Officer

Idorsia appoints Roland Wandeler as Chief Executive Officer Ad hoc announcement pursuant to Art. 53 LR Idorsia appoints Roland Wandeler as CEO –...

Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility

Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility Allschwil, Switzerland – June 26...

Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon

Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon Ad hoc announcement pursuant to Art. 53 LR Senior secured...

Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology

Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology...

New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension

New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.75	11.6099071207	6.46	8.19	6.455	12633	7.41074883	DE
4	2.3280001	47.6853778715	4.8819999	8.19	4.5	9683	6.36347399	DE
12	3.41	89.7368421053	3.8	8.19	3.682	9476	5.05102875	DE
26	2.42	50.5219206681	4.79	8.19	3.11	10187	4.43992219	DE
52	4.695	186.679920477	2.515	8.19	2.375	10825	4.05787972	DE
156	5.792	408.462623413	1.418	8.19	1.332	10516	3.83058147	DE
260	5.792	408.462623413	1.418	8.19	1.332	10516	3.83058147	DE

19T - Frequently Asked Questions (FAQ)

What is the current Idorsia Ltd share price?

The current share price of Idorsia Ltd is 7,21 €

What is the 1 year trading range for Idorsia Ltd share price?

Idorsia Ltd has traded in the range of 2,375 € to 8,19 € during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Idorsia Ltd (19T)

Idorsia Ltd (19T) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

19T Dernières nouvelles

Idorsia appoints Roland Wandeler as Chief Executive Officer

Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility

Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon

Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology

New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension

Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2026

Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year

Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders

Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development

Idorsia’s daridorexant delivers outstanding results in a Phase 2 study in children with insomnia disorder

19T - Frequently Asked Questions (FAQ)

19T Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Idorsia Ltd (19T)

Idorsia Ltd (19T) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

19T Dernières nouvelles

Idorsia appoints Roland Wandeler as Chief Executive Officer

Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility

Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon

Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology

New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension

Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2026

Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year

Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders

Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development

Idorsia’s daridorexant delivers outstanding results in a Phase 2 study in children with insomnia disorder

19T - Frequently Asked Questions (FAQ)

19T Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités